FCX
61
3
SWKS
55
5
KR
44
6
JNPR
50
4
DRI
60
7
LUV
45
5
FMC
40
6
NEM
48
2
HAS
37
4
CF
50
-7
WEC
56
3
AKAM
53
2
PX
78
2
URBN
52
-4
CA
47
9
UNP
60
8
LEG
50
14
GPC
45
5
REGN
42
3
JNJ
47
3
FCX
61
3
SWKS
55
5
KR
44
6
JNPR
50
4
DRI
60
7
LUV
45
5
FMC
40
6
NEM
48
2
HAS
37
4
CF
50
-7
WEC
56
3
AKAM
53
2
PX
78
2
URBN
52
-4
CA
47
9
UNP
60
8
LEG
50
14
GPC
45
5
REGN
42
3
JNJ
47
3
Financhill
Back

Biomarin Pharmaceutical Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
64

BMRN
Biomarin Pharmaceutical

Last Price:
64.87
Seasonality Move:
8.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Biomarin Pharmaceutical Price Quote

$64.87
-0.22 (-0.34%)
(Updated: November 26, 2024 at 5:55 PM ET)

Biomarin Pharmaceutical Key Stats

Buy
64
Biomarin Pharmaceutical (BMRN) is a Buy
Day range:
$64.32 - $65.69
52-week range:
$61.15 - $99.56
Dividend yield:
0%
P/E ratio:
74.82
P/S ratio:
4.64
P/B ratio:
2.29%
Volume:
2.1M
Avg. volume:
1.5M
1-year change:
-26.19%
Market cap:
$12.4B
Revenue:
$2.4B
EPS:
$1.67

How Much Does Biomarin Pharmaceutical Make?

Is Biomarin Pharmaceutical Growing As A Company?

Biomarin Pharmaceutical Stock Price Performance

What Is Biomarin Pharmaceutical 52-Week High & Low?

Biomarin Pharmaceutical Price To Free Cash Flow

Is It Risky To Buy Biomarin Pharmaceutical?

Is Biomarin Pharmaceutical Cash Flow Positive?

  • What Is BMRN Cash Flow From Operations?
    Cash flow from operations (TTM) is $414.7M
  • What Is Biomarin Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$518.5M
  • What Is Biomarin Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$4.9M

Biomarin Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    BMRN return on invested capital is 5.27%
  • What Is Biomarin Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is 4.69%
  • What Is BMRN Return On Equity?
    ROE is a measure of profitability and is 6.29%

Biomarin Pharmaceutical Earnings Date & Stock Price

Biomarin Pharmaceutical Competitors

Biomarin Pharmaceutical Dividend Yield

Biomarin Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: 161.91% 14.73%
Revenue: 28.28% 6.03%

Analyst Recommendations

Buy Recommendations: 14
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 98.39
Upside from Last Price: 51.15%

Major Shareholders

  • How many BMRN shares are owned by institutional investors?
    317.3M BMRN shares are owned by institutional investors
  • How many BMRN shares are owned by insiders?
    2.5M BMRN shares are owned by insiders